Several groups have consistently reported that TIGIT is highly expressed on CD8+ TILs in many cancers, such as nonsmall cell lung cancer, colon cancer, melanoma [34, 79], and acute myelogenous leukemia [83]. Here, TIGIT is linked to cancer.